HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R J Gibbons Selected Research

Infarction (Infarctions)

4/2010Application of technetium-99m sestamibi single photon emission computed tomography in acute myocardial infarction: measuring the efficacy of therapy.
12/2001Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study.
9/2001An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study).
1/2001Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction.
8/2000The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation).
7/2000Infarct size determination by technetium 99m sestamibi single-photon emission computed tomography predicts survival in patients with chronic coronary artery disease.
5/2000The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion.
1/2000Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R J Gibbons Research Topics

Disease

10Myocardial Infarction
04/2010 - 01/2000
8Infarction (Infarctions)
04/2010 - 01/2000
5Coronary Artery Disease (Coronary Atherosclerosis)
10/2001 - 02/2000
2Heart Failure
08/2009 - 12/2001
2Coronary Occlusion
08/2000 - 05/2000
1Fibrosis (Cirrhosis)
04/2010
1Hypotension (Low Blood Pressure)
08/2009
1Trichothiodystrophy Syndromes
11/2001
1Hypertension (High Blood Pressure)
10/2001
1Pathologic Constriction (Stenosis)
10/2001
1Bundle-Branch Block (Fascicular Block)
10/2001
1Pre-Excitation Syndromes (Pre-Excitation Syndrome)
10/2001
1Infections
09/2001
1Out-of-Hospital Cardiac Arrest
07/2000
1Death (Near-Death Experience)
07/2000
1Epilepsy (Aura)
01/2000
1Intellectual Disability (Idiocy)
01/2000

Drug/Important Bio-Agent (IBA)

3Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
01/2001 - 05/2000
2Technetium (Technetium 99m)IBA
04/2010 - 09/2009
2Biomarkers (Surrogate Marker)IBA
04/2010 - 01/2000
2Monoclonal AntibodiesIBA
12/2001 - 09/2001
2Radioisotopes (Radionuclides)IBA
01/2001 - 08/2000
2ThalliumIBA
02/2000 - 01/2000
1Brain Natriuretic Peptide (Natrecor)FDA Link
08/2009
1AldosteroneIBA
08/2009
1Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2001
1CD18 AntigensIBA
12/2001
1Tissue Plasminogen Activator (Alteplase)FDA Link
12/2001
1adhesion receptorIBA
12/2001
1Transcription Factor TFIIHIBA
11/2001
1LDL CholesterolIBA
10/2001
1rovelizumabIBA
09/2001
1Vasodilator Agents (Vasodilators)IBA
07/2001
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2001
1Digoxin (Digitek)FDA LinkGeneric
12/2000
1Adenosine (Adenocard)FDA LinkGeneric
12/2000
1Poloxamer (Poloxamer 407)IBA
08/2000
1Thallium-201IBA
02/2000
1RadiopharmaceuticalsIBA
01/2000
1Nonsense Codon (Nonsense Mutation)IBA
01/2000

Therapy/Procedure

3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2001 - 07/2000
2Therapeutics
04/2010 - 01/2000
1Thrombolytic Therapy
04/2002
1Lung Transplantation
12/2001
1Catheters
08/2000
1Stents
05/2000